Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BeeCovid2: Propolis for Hospitalized COVID-19
NCT04800224Phase 3Completed
- Sponsor
- Instituto D’Or de Pesquisa e Ensino
- Start
- Apr 2021
- Primary completion
- Jul 2021
- Modality
- Hydrogel Systems, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 3 trial of Brazilian green propolis extract in coronavirus disease 2019 (COVID-19), sponsored by Instituto D’Or de Pesquisa e Ensino. Started Apr 2021; status: completed.
02
Drugs
Brazilian green propolis extract
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04800224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04800224.